577 related articles for article (PubMed ID: 16277683)
21. Association of HLA alleles and clinical features in patients with synovitis of recent onset.
El-Gabalawy HS; Goldbach-Mansky R; Smith D; Arayssi T; Bale S; Gulko P; Yarboro C; Wilder RL; Klippel JH; Schumacher HR
Arthritis Rheum; 1999 Aug; 42(8):1696-705. PubMed ID: 10446870
[TBL] [Abstract][Full Text] [Related]
22. Contribution of PTPN22 1858T, TNFRII 196R and HLA-shared epitope alleles with rheumatoid factor and anti-citrullinated protein antibodies to very early rheumatoid arthritis diagnosis.
Goëb V; Dieudé P; Daveau R; Thomas-L'otellier M; Jouen F; Hau F; Boumier P; Tron F; Gilbert D; Fardellone P; Cornélis F; Le Loët X; Vittecoq O
Rheumatology (Oxford); 2008 Aug; 47(8):1208-12. PubMed ID: 18535030
[TBL] [Abstract][Full Text] [Related]
23. Regulation of anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis: contrasting effects of HLA-DR3 and the shared epitope alleles.
Irigoyen P; Lee AT; Wener MH; Li W; Kern M; Batliwalla F; Lum RF; Massarotti E; Weisman M; Bombardier C; Remmers EF; Kastner DL; Seldin MF; Criswell LA; Gregersen PK
Arthritis Rheum; 2005 Dec; 52(12):3813-8. PubMed ID: 16320316
[TBL] [Abstract][Full Text] [Related]
24. The HLA-DRB1 shared epitope alleles are primarily a risk factor for anti-cyclic citrullinated peptide antibodies and are not an independent risk factor for development of rheumatoid arthritis.
van der Helm-van Mil AH; Verpoort KN; Breedveld FC; Huizinga TW; Toes RE; de Vries RR
Arthritis Rheum; 2006 Apr; 54(4):1117-21. PubMed ID: 16572446
[TBL] [Abstract][Full Text] [Related]
25. PTPN22 polymorphism and anti-cyclic citrullinated peptide antibodies in combination strongly predicts future onset of rheumatoid arthritis and has a specificity of 100% for the disease.
Johansson M; Arlestig L; Hallmans G; Rantapää-Dahlqvist S
Arthritis Res Ther; 2006; 8(1):R19. PubMed ID: 16507117
[TBL] [Abstract][Full Text] [Related]
26. Interaction between smoking, the shared epitope, and anti-cyclic citrullinated peptide: a mixed picture in three large North American rheumatoid arthritis cohorts.
Lee HS; Irigoyen P; Kern M; Lee A; Batliwalla F; Khalili H; Wolfe F; Lum RF; Massarotti E; Weisman M; Bombardier C; Karlson EW; Criswell LA; Vlietinck R; Gregersen PK
Arthritis Rheum; 2007 Jun; 56(6):1745-53. PubMed ID: 17530703
[TBL] [Abstract][Full Text] [Related]
27. Quantitative heritability of anti-citrullinated protein antibody-positive and anti-citrullinated protein antibody-negative rheumatoid arthritis.
van der Woude D; Houwing-Duistermaat JJ; Toes RE; Huizinga TW; Thomson W; Worthington J; van der Helm-van Mil AH; de Vries RR
Arthritis Rheum; 2009 Apr; 60(4):916-23. PubMed ID: 19333951
[TBL] [Abstract][Full Text] [Related]
28. Smoking intensity, duration, and cessation, and the risk of rheumatoid arthritis in women.
Costenbader KH; Feskanich D; Mandl LA; Karlson EW
Am J Med; 2006 Jun; 119(6):503.e1-9. PubMed ID: 16750964
[TBL] [Abstract][Full Text] [Related]
29. Antifilaggrin antibodies within "normal" range predict rheumatoid arthritis in a linear fashion.
Aho K; Palosuo T; Heliövaara M; Knekt P; Alha P; von Essen R
J Rheumatol; 2000 Dec; 27(12):2743-6. PubMed ID: 11128658
[TBL] [Abstract][Full Text] [Related]
30. No increased occurrence of ischemic heart disease prior to the onset of rheumatoid arthritis: results from two Swedish population-based rheumatoid arthritis cohorts.
Holmqvist ME; Wedrén S; Jacobsson LT; Klareskog L; Nyberg F; Rantapää-Dahlqvist S; Alfredsson L; Askling J
Arthritis Rheum; 2009 Oct; 60(10):2861-9. PubMed ID: 19790058
[TBL] [Abstract][Full Text] [Related]
31. Associations between genetic factors, tobacco smoking and autoantibodies in familial and sporadic rheumatoid arthritis.
Michou L; Teixeira VH; Pierlot C; Lasbleiz S; Bardin T; Dieudé P; Prum B; Cornélis F; Petit-Teixeira E
Ann Rheum Dis; 2008 Apr; 67(4):466-70. PubMed ID: 17660221
[TBL] [Abstract][Full Text] [Related]
32. Familial seropositive rheumatoid arthritis in North American Native families: effects of shared epitope and cytokine genotypes.
Oen K; Robinson DB; Nickerson P; Katz SJ; Cheang M; Peschken CA; Canvin JM; Hitchon CA; Schroeder ML; El-Gabalawy HS
J Rheumatol; 2005 Jun; 32(6):983-91. PubMed ID: 15940756
[TBL] [Abstract][Full Text] [Related]
33. Detailed analysis of the variability of peptidylarginine deiminase type 4 in German patients with rheumatoid arthritis: a case-control study.
Hoppe B; Häupl T; Gruber R; Kiesewetter H; Burmester GR; Salama A; Dörner T
Arthritis Res Ther; 2006; 8(2):R34. PubMed ID: 16469113
[TBL] [Abstract][Full Text] [Related]
34. [The role of anti-cyclic citrullinated peptide (anti-CCP) antibodies in serologic diagnosis and evaluation of disease activity in rheumatoid arthritis].
Aridoğan BC; Kaya S; Savaş S; Cetin ES; Akkuş S; Demirci M
Mikrobiyol Bul; 2008 Oct; 42(4):669-74. PubMed ID: 19149089
[TBL] [Abstract][Full Text] [Related]
35. Do rheumatoid arthritis and lymphoma share risk factors?: a comparison of lymphoma and cancer risks before and after diagnosis of rheumatoid arthritis.
Hellgren K; Smedby KE; Feltelius N; Baecklund E; Askling J
Arthritis Rheum; 2010 May; 62(5):1252-8. PubMed ID: 20155827
[TBL] [Abstract][Full Text] [Related]
36. The risk of congestive heart failure in rheumatoid arthritis: a population-based study over 46 years.
Nicola PJ; Maradit-Kremers H; Roger VL; Jacobsen SJ; Crowson CS; Ballman KV; Gabriel SE
Arthritis Rheum; 2005 Feb; 52(2):412-20. PubMed ID: 15692992
[TBL] [Abstract][Full Text] [Related]
37. Anti-CCP2 is an adjunct to, not a surrogate for, rheumatoid factor in the diagnosis of rheumatoid arthritis: diagnostic utility of anti-CCP2 antibodies in Egyptian patients with rheumatoid arthritis.
Abdel-Nasser AM; Mahmoud MH; El Mansoury TM; Osman AM
Scand J Rheumatol; 2008; 37(5):329-36. PubMed ID: 18666028
[TBL] [Abstract][Full Text] [Related]
38. Declining trend in the incidence of rheumatoid factor-positive rheumatoid arthritis in Finland 1980-2000.
Kaipiainen-Seppanen O; Kautiainen H
J Rheumatol; 2006 Nov; 33(11):2132-8. PubMed ID: 17014003
[TBL] [Abstract][Full Text] [Related]
39. Thyroxin substitution and the risk of developing rheumatoid arthritis; results from the Swedish population-based EIRA study.
Bengtsson C; Padyukov L; Källberg H; Saevarsdottir S
Ann Rheum Dis; 2014 Jun; 73(6):1096-100. PubMed ID: 23613482
[TBL] [Abstract][Full Text] [Related]
40. Association of the PD-1.3A allele of the PDCD1 gene in patients with rheumatoid arthritis negative for rheumatoid factor and the shared epitope.
Prokunina L; Padyukov L; Bennet A; de Faire U; Wiman B; Prince J; Alfredsson L; Klareskog L; Alarcón-Riquelme M
Arthritis Rheum; 2004 Jun; 50(6):1770-3. PubMed ID: 15188352
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
